Research Paper Volume 11, Issue 15 pp 5483—5497

Figure 3. Upregulation of CBX3/HP1γ is associated with poor prognosis in liver cancer. (A) Upregulation of CBX3/HP1γ in liver cancer was confirmed in the UALCAN database (60.5 per million in primary tumor vs. 29.6 per million in normal tissue, P value = 1.62e-12). (B) Prognostic significance of CBX3/HP1γ expression in liver cancer in the Human Protein Atlas database. (C) Survival curve based on CBX3/HP1γ expression from the UALCAN web-portal (log-rank test P value < 0.0001). (D) Survival curve based on CBX3/HP1γ expression level from the Kaplan–Meier plotter survival analysis platforms (HR=2.37 (1.67-3.36), log-rank test P value = 6.9E-7).